Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9201 USD | -17.11% | -26.98% | -60.17% |
Apr. 18 | ADRs End Lower; Genetic Technologies Declines 23% | DJ |
Apr. 18 | Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading | MT |
Sales 2024 * | 1.83B 253M | Sales 2025 * | - | Capitalization | 1.56B 216M |
---|---|---|---|---|---|
Net income 2024 * | -2.9B -401M | Net income 2025 * | - | EV / Sales 2024 * | 0.85 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.61
x | P/E ratio 2025 * |
-
| Employees | 541 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.9% |
Latest transcript on Canaan Inc.
1 day | -17.11% | ||
1 week | -26.98% | ||
Current month | -39.47% | ||
1 month | -29.22% | ||
3 months | -49.99% | ||
6 months | -47.42% | ||
Current year | -60.17% |
Managers | Title | Age | Since |
---|---|---|---|
N. G. Zhang
CEO | Chief Executive Officer | 41 | 12-12-31 |
James Cheng
DFI | Director of Finance/CFO | 45 | 21-08-01 |
Xi Zhang
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
N. G. Zhang
CEO | Chief Executive Officer | 41 | 12-12-31 |
Ya Ping Zhang
BRD | Director/Board Member | 49 | 20-07-31 |
Wen Jun Zhang
BRD | Director/Board Member | 58 | 20-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.9201 | -17.11% | 19,317,074 |
24-04-17 | 1.11 | +0.91% | 6,649,491 |
24-04-16 | 1.1 | -2.65% | 9,159,289 |
24-04-15 | 1.13 | -5.83% | 8,681,107 |
24-04-12 | 1.2 | -4.76% | 6,011,599 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.17% | 216M | |
+66.04% | 785M | |
-46.14% | 51.75M |
- Stock Market
- Equities
- CAN Stock